Skip to main content
You are the owner of this article.
You have permission to edit this article.
Edit
CEO of Louisiana compounding pharmacy pleads guilty in NJ health care fraud scheme
top story

CEO of Louisiana compounding pharmacy pleads guilty in NJ health care fraud scheme

{{featured_button_text}}
Federal Court in Camden

Mitchell H. Cohen Building and U.S. Courthouse in Camden

CAMDEN — The chief executive officer of a Louisiana pharmacy used by numerous individuals to defraud New Jersey health benefits programs and other insurers out of more than $50 million has pleaded guilty to her role in the scheme.

Hayley Taff, 37, of Louisiana-based Central Rexall Drugs, pleaded guilty by videoconference before U.S. District Judge Robert B. Kugler to one count of conspiracy to commit health care fraud.

The latest indictment ties together several of the many threads in the case, which first came to light in summer 2017 when Margate received a subpoena for its employees’ health benefit information. Since then, more than 30 people have been charged in the scheme.

Prosecutors have said the scheme centers on the billing of the state’s public employee health benefit plans for medically unnecessary compounded drugs, with payouts from prescription reimbursements going to line the pockets of all participants.

Support Local Journalism

Your subscription makes our reporting possible.
{{featured_button_text}}

The company designed compounded medications and manipulated the ingredients to determine the highest reimbursement rate, court documents show. When pharmacy benefits administrators stopped covering one combination, the company would compound different medications based solely on insurance reimbursement.

According to court documents, Taff admitted during the scheme the company stopped being concerned about the health impacts of their compounded medications. The company devoted itself solely to making money, the court documents show.

Taff’s conspirators designed compounded medications and manipulated the ingredients in the medications to obtain high insurance reimbursements rather than serve the medical needs of patients, according to court documents.

Taff faces a maximum of 10 years in prison and a $250,000 fine, or twice the gain or loss from the offense. As part of the plea agreement, Taff must pay restitution of $51,670,251 and forfeiture of $1,553,616. Sentencing for is scheduled for Dec. 1.

Contact: 609-272-7046

nhuba@pressofac.com

Twitter @acpresshuba

Be the first to know

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

The best local coverage, unlimited

Sign up for a digital subscription to The Press of Atlantic City now and take advantage of a great offer.

LEARN MORE

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

PLEASE BE ADVISED: Soon we will no longer integrate with Facebook for story comments. The commenting option is not going away, however, readers will need to register for a FREE site account to continue sharing their thoughts and feedback on stories. If you already have an account (i.e. current subscribers, posting in obituary guestbooks, for submitting community events), you may use that login, otherwise, you will be prompted to create a new account.

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News